Panion & BF Biotech Inc
TWSE:1760

Watchlist Manager
Panion & BF Biotech Inc Logo
Panion & BF Biotech Inc
TWSE:1760
Watchlist
Price: 66.5 TWD -0.3%
Market Cap: 5.7B TWD

Relative Value

The Relative Value of one Panion & BF Biotech Inc stock under the Base Case scenario is hidden TWD. Compared to the current market price of 66.5 TWD, Panion & BF Biotech Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Panion & BF Biotech Inc Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
95
vs Industry
33
Median 3Y
4.2
Median 5Y
4.2
Industry
2.6
Forward
2.8
vs History
95
vs Industry
7
Median 3Y
59.1
Median 5Y
63.9
Industry
21.7
Forward
40.6
vs History
73
vs Industry
22
Median 3Y
20.3
Median 5Y
20.9
Industry
16.6
vs History
23
vs Industry
11
Median 3Y
52.1
Median 5Y
39.9
Industry
22.5
vs History
93
vs Industry
20
Median 3Y
4.5
Median 5Y
4.7
Industry
2.3
vs History
85
vs Industry
33
Median 3Y
4.3
Median 5Y
4.4
Industry
2.9
Forward
3.1
vs History
93
vs Industry
32
Median 3Y
8.1
Median 5Y
8.7
Industry
5.5
vs History
95
vs Industry
19
Median 3Y
22.8
Median 5Y
24.3
Industry
13.1
Forward
19.8
vs History
95
vs Industry
13
Median 3Y
37.9
Median 5Y
41.1
Industry
16.6
Forward
24.7
vs History
63
vs Industry
22
Median 3Y
20.9
Median 5Y
21.3
Industry
15.8
vs History
61
vs Industry
11
Median 3Y
40.2
Median 5Y
40.5
Industry
19.1
vs History
95
vs Industry
26
Median 3Y
3.3
Median 5Y
3.3
Industry
1.9

Multiples Across Competitors

Competitors Multiples
Panion & BF Biotech Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
TW
Panion & BF Biotech Inc
TWSE:1760
5.7B TWD 2.8 32.9 14.8 21.7
US
Eli Lilly and Co
NYSE:LLY
929B USD 15.6 50.5 33.9 36.4
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
481.1B USD 5.2 19.2 15.7 20.4
CH
Roche Holding AG
SIX:ROG
251.1B CHF 4.1 26.6 11.4 13.3
UK
AstraZeneca PLC
LSE:AZN
210.8B GBP 4.8 29.8 108.1 158.2
CH
Novartis AG
SIX:NOVN
205B CHF 4.5 17.7 11.2 14.5
US
Merck & Co Inc
NYSE:MRK
241B USD 3.8 12.7 9.1 10.7
DK
Novo Nordisk A/S
CSE:NOVO B
1.3T DKK 4.2 12.8 9 10.4
IE
Endo International PLC
LSE:0Y5F
202.5B USD 87.3 -69.3 321.2 805.4
US
Pfizer Inc
NYSE:PFE
144B USD 2.3 14.7 7.5 10.2
P/E Multiple
Earnings Growth PEG
TW
Panion & BF Biotech Inc
TWSE:1760
Average P/E: 24.1
32.9
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
50.5
53%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.2
29%
0.7
CH
Roche Holding AG
SIX:ROG
26.6
29%
0.9
UK
AstraZeneca PLC
LSE:AZN
29.8
38%
0.8
CH
Novartis AG
SIX:NOVN
17.7
17%
1
US
Merck & Co Inc
NYSE:MRK
12.7
15%
0.8
DK
Novo Nordisk A/S
CSE:NOVO B
12.8
4%
3.2
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -69.3 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.7
29%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
TW
Panion & BF Biotech Inc
TWSE:1760
Average EV/EBITDA: 398.9
14.8
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
33.9
33%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
15.7
9%
1.7
CH
Roche Holding AG
SIX:ROG
11.4
4%
2.9
UK
AstraZeneca PLC
LSE:AZN
108.1
10%
10.8
CH
Novartis AG
SIX:NOVN
11.2
6%
1.9
US
Merck & Co Inc
NYSE:MRK
9.1
6%
1.5
DK
Novo Nordisk A/S
CSE:NOVO B
9
2%
4.5
IE
E
Endo International PLC
LSE:0Y5F
321.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.5
1%
7.5
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
TW
Panion & BF Biotech Inc
TWSE:1760
Average EV/EBIT: 1 709.4
21.7
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
36.4
36%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
20.4
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.3
5%
2.7
UK
AstraZeneca PLC
LSE:AZN
158.2
23%
6.9
CH
Novartis AG
SIX:NOVN
14.5
12%
1.2
US
Merck & Co Inc
NYSE:MRK
10.7
8%
1.3
DK
Novo Nordisk A/S
CSE:NOVO B
10.4
1%
10.4
IE
E
Endo International PLC
LSE:0Y5F
805.4
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.2
8%
1.3